PREVALENCE AND MANAGEMENT OF MATERNAL DEATHS DUE TO ECLAMPSIA AND HELLP SYNDROME: A COMPREHENSIVE SYSTEMATIC REVIEW
DOI:
https://doi.org/10.61841/2sb1s408Keywords:
Eclampsia, HELLP syndrome, prevalence, treatmentAbstract
Background: Eclampsia and HELLP syndrome, are serious complications during pregnancy, and pose significant risks to both mother and fetus. Early management of eclampsia and HELLP syndrome before delivery may improve the outcomes for patients. This study aims to systematically review the literature on the prevalence and management of eclampsia and HELLP syndrome regarding maternal deaths in the last 10 years.
Methods: This systematic review used the PRISMA 2020 guidelines and focused on full-text English literature published between 2014 and 2024. Editorials and review papers from the same journal, as well as submissions without a DOI, were not considered. Literature was gathered from online databases such as PubMed, SagePub, and ScienceDirect.
Result: In the initial stages, our research team retrieved a total of 9400 articles from reputable sources such as PubMed, SagePub, and Science Direct. After a meticulous three-level screening process, only six articles were deemed directly relevant to our ongoing systematic review and were selected for further analysis through thorough full-text reading.
Conclusion: Eclampsia and HELLP syndrome are both conditions that require treatment. Pregnancy termination and magnesium supplementation prevent eclampsia, while glucocorticoids are crucial for treating HELLP syndrome. Treatment should consider baseline features and long-term implications to address maternal and fetal health and well-being.
References
Tjandraprawira, K. D., Kusumah, A. Y., Kamilah, A. Y., Putri, D. I., Ananta, M. R., Sari, S. P., Djuwantono, T., & Petrie, A. (2021). Management and perinatal outcomes of hypertensive disorders of pregnancy in a low-resource setting in Indonesia. 38. https://doi.org/10.1177/20503121211060194
Magley M, Hinson MR. Eclampsia. [Updated 2023 Jan 30]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554392/
Gracia, P. V., Rojas-suarez, J., Ramos, E., Reyes, O., Collantes, J., Quintero, A., Huertas, E., Calle, A., Turcios, E., & Chon, V. Y. (2015). International Journal of Gynecology and Obstetrics Incidence of eclampsia with HELLP syndrome and associated mortality in Latin America. International Journal of Gynecology and Obstetrics. https://doi.org/10.1016/j.ijgo.2014.11.024
Adorno M, Maher-Griffiths C, Grush Abadie HR. HELLP Syndrome. Crit Care Nurs Clin North Am. 2022 Sep;34(3):277–88.
Khalid F, Mahendraker N, Tonismae T. HELLP Syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Feb 20]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK560615/
Wallace K, Harris S, Addison A, Bean C. HELLP Syndrome: Pathophysiology and Current Therapies. Curr Pharm Biotechnol. 2018;19(10):816–26.
Sun, W.-J., Hu, J., Zhang, Q., & Shan, J.-M. (2023). Administration of corticosteroid therapy for HELLP syndrome in pregnant women: evidences from seven randomized controlled trials. Hypertension in Pregnancy, 42(1), 2276726. https://doi.org/10.1080/10641955.2023.2276726
Gracia, P. V., Ramirez, R., Durán, Y., & Quintero, A. (2017). Magnesium sulfate for 6 vs 24 hours post delivery in patients who received magnesium sulfate for less than 8 hours before birth : a randomized clinical trial. 4–9. https://doi.org/10.1186/s12884-017-1424-3
Wen, S. W., White, R. R., Rybak, N., Gaudet, L. M., Robson, S., Hague, W., Simms-Stewart, D., Carroli, G., Smith, G., Fraser, W. D., Wells, G., Davidge, S. T., Kingdom, J., Coyle, D., Fergusson, D., Corsi, D. J., Champagne, J., Sabri, E., Ramsay, T., … Walker, M. C. (2018). Effect of high dose folic acid supplementation in pregnancy on pre-eclampsia (FACT): double blind, phase III, randomised controlled, international, multicentre trial. BMJ (Clinical Research Ed.), 362, k3478. https://doi.org/10.1136/bmj.k3478
Kang, S., Zhou, L., Wang, X., Li, Y., & Wang, Y. (2019). Effectiveness of high-dose glucocorticoids on hemolysis, elevating liver enzymes, and reducing platelets syndrome. The Journal of International Medical Research, 47(2), 738–747. https://doi.org/10.1177/0300060518809783
Pascoal, A. C. F., Katz, L., Pinto, M. H., Santos, C. A., Braga, L. C. O., Maia, S. B., & Amorim, M. M. R. (2019). Serum magnesium levels during magnesium sulfate infusion at 1 gram/hour versus 2 grams/hour as a maintenance dose to prevent eclampsia in women with severe preeclampsia: A randomized clinical trial. Medicine, 98(32), e16779. https://doi.org/10.1097/MD.0000000000016779
Vousden, N., Lawley, E., Seed, P. T., Gidiri, M. F., Goudar, S., Sandall, J., Chappell, L. C., & Shennan, A. H. (2019). Incidence of eclampsia and related complications across 10 low- and middle- resource geographical regions : Secondary analysis of a cluster randomised controlled trial. PLoS Medicine, April 2016, 1–15.
Cui, C., Ma, S., & Qiao, R. (2020). Prenatal Plasma Fibrinogen Level Predicts Postpartum Hemorrhage of Patients With HELLP Syndrome. Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 26, 1076029619894057. https://doi.org/10.1177/1076029619894057
Duvekot, J. J., Duijnhoven, R. G., van Horen, E., Bax, C. J., Bloemenkamp, K. W., Brussé, I. A., Dijk, P. H., Franssen, M. T., Franx, A., Oudijk, M. A., Porath, M. M., Scheepers, H. C., van Wassenaer-Leemhuis, A. G., van Drongelen, J., Mol, B. W., & Ganzevoort, W. (2021). Temporizing management vs immediate delivery in early-onset severe preeclampsia between 28 and 34 weeks of gestation (TOTEM study): An open-label randomized controlled trial. Acta Obstetricia et Gynecologica Scandinavica, 100(1), 109–118. https://doi.org/10.1111/aogs.13976
Okusanya, B. O., Oladapo, O. T., Long, Q., Lumbiganon, P., Carroli, G., Qureshi, Z., Duley, L., Souza, J. P., & Gülmezoglu, A. M. (2016). Clinical pharmacokinetic properties of magnesium sulphate in women with pre-eclampsia and eclampsia. BJOG : An International Journal of Obstetrics and Gynaecology, 123(3), 356–366. https://doi.org/10.1111/1471-0528.13753
Duley, L., Gülmezoglu, A. M., Henderson-Smart, D. J., & Chou, D. (2010). Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. The Cochrane Database of Systematic Reviews, 2010(11), CD000025. https://doi.org/10.1002/14651858.CD000025.pub2
Abbassi-Ghanavati, M., Alexander, J. M., McIntire, D. D., Savani, R. C., & Leveno, K. J. (2012). Neonatal effects of magnesium sulfate given to the mother. American Journal of Perinatology, 29(10), 795–799. https://doi.org/10.1055/s-0032-1316440
Vigil-De Garcia, P., Tejada, O., Minaca, A., Tellez, G., Chon, V., Herrarte, E., Villar, A., & Ludmir, J. (2013). Expectant management of severe preeclampsia remote from term : the MEXPRE Latin Study , a randomized , multicenter clinical trial. American Journal of Obstetrics & Gynecology, 425 (November). https://doi.org/10.1016/j.ajog.2013.08.016
Evensen, A. N. N., Health, P., Anderson, W. J. M., Family, F., Residency, M., & Fontaine, P. P. (2017). Postpartum Hemorrhage: Prevention and Treatment.
Haram, K., Mortensen, J. H., Mastrolia, S. A., & Erez, O. (2016). Disseminated intravascular coagulation in the HELLP syndrome: how much do we really know? Kjell. The Journal of Maternal-Fetal & Neonatal Medicine, 7058(May). https://doi.org/10.1080/14767058.2016.1189897
Yang, L., Ren, C., Mao, M., & Cui, S. (2016). Prognostic Factors of the Efficacy of High-dose Corticosteroid Therapy in Hemolysis , Elevated Liver Enzymes , and Low Platelet Count Syndrome During Pregnancy. Medicine, 95(13), 1–7. https://doi.org/10.1097/MD.0000000000003203
Pourrat, O., Dorey, M., Ragot, S., Hauteclocque, A., & Deruelle, P. (2016). High-Dose Methylprednisolone to Prevent Platelet Decline in Preeclampsia. The American College of Obstetricians and Gynecologist, 128(1), 153–158. https://doi.org/10.1097/AOG.0000000000001470
Morhart, P., Gärtner, J., Weiss, C., Stumpfe, F. M., Dammer, U., Faschingbauer, F., Fahlbusch, F. B., Beckmann, M. W., & Kehl, S. (2022). Influence of Timing of Antenatal Corticosteroid Administration on Morbidity of Preterm Neonates. In Vivo (Athens, Greece), 36(4), 1777–1784. https://doi.org/10.21873/invivo.12891
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Mu’arif Ramadhan, Yohanes Putu Arianta
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
